Cellectar Biosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLRB and other ETFs, options, and stocks.About CLRB
Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124, which could detect tumors and metastases in a broad range of cancers, and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination.
CLRB Key Statistics
Stock Snapshot
With a market cap of 10.87M, Cellectar Biosciences(CLRB) trades at $1.14. The stock has a price-to-earnings ratio of -0.25.
On 2026-10-17, Cellectar Biosciences(CLRB) stock moved within a range of $1.12 to $1.28. With shares now at $1.14, the stock is trading +2.0% above its intraday low and -10.8% below the session's peak.
Trading activity shows a volume of 341.22K, compared to an average daily volume of 242.85K.
Over the past 52 weeks, Cellectar Biosciences(CLRB) stock has traded between a high of $5.03 and a low of $1.12.
Over the past 52 weeks, Cellectar Biosciences(CLRB) stock has traded between a high of $5.03 and a low of $1.12.
CLRB News
...
Cellectar Biosciences (CLRB) announced that efficacy results from a subset of patients treated with iopofosine I 131 immediately post-Bruton Tyrosine Kinase inh...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.